Rheumatology

SAPHNELO

SAPHNELO (anifrolumab-fnia) is a prescription medicine given intravenously used to treat adults
Infusion or injection therapy referral
What it treats Systemic Lupus Erythematosus (SLE)
Prescribed by Rheumatologists
How it’s administered Intravenous (IV) infusion
Frequency Every four weeks
Length of treatment 30 minutes

About This Therapy

SAPHNELO (anifrolumab-fnia) is a prescription medicine given intravenously used to treat adults with moderate to severe systemic lupus erythematosus (SLE or lupus) who are receiving other lupus medicines.

For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.

SAPHNELO REFERRAL FORM

SAPHNELO REFERRAL FORM

Speak with your healthcare provider to learn if this therapy is right for you, then complete the referral form below.

Ready to refer a patient for SAPHNELO

Our team handles benefits verification, prior authorization, and scheduling so you can focus on care.